BPS 2018 Proceedings with Videos | Boulder Peptide Symposium

Young Investigator Keynote address

Jevgenij Raskatov

Assistant Professor in Biochemistry and Chemistry
University California Santa Cruz

Chirality, Alzheimer's Disease, and Amyloid Beta

Peptide Showcase

Brief 15 minute presentations from companies developing peptide therapeutics and related technologies. This rapid and compressed format is designed for quick introduction between symposium participants to new technologies, and companies. Each presentation is structured to highlight the value of the technology or therapeutic being offered and the business strategy.

Martin Handfield

Senior VP, Research
Oragenics

Lantibiotics for the Treatment of Clostridium difficile Associated Disease

David Guay

David
Feldan Therapeutics

Novel peptide technology to deliver proteins and CRISPR ribonucleoproteins in cells

Amit Michaeli

CTO
Pepticom Ltd.

Ab initio Computational Peptide Discovery: Concepts and Examples.

Michael Coe

Chief Scientific Officer
Phoreus Biotechnology, Inc.

Redefining Bio-Delivery with Peptide Nanotechnology

Jennifer Neff

Jennifer
Allvivo Vascular

Engineered antimicrobial peptides and their application to prevent medical device associated infections

Melvin Klegerman

Professor
University of Texas Health Science Center at Houston

A Fibrin-Binding Peptide for Targeting Drug-Loaded Liposomes to Atherosclerotic Plaques

Philip Kim

Associate Professor
University of Toronto

Method to generate highly stable D-amino acid analogs of bioactive helical peptides using a mirror image of the entire . . .

Meredith Hay

Founder and CSO
ProNeurogen

Glycoslyated Angiotensin 1-7 as novel treatment for cognitive impairment

Maria Soloveychik

CEO
SyntheX

Cell based production and selection of PPI-modulating peptides and applications in oncology.

Carola Leuschner

Consultant for Intendet Services
Intendet Services LLC

Novel peptides for immune stimulation and synergy with checkpoint inhibitors

Dwight Morrow

VP Preclinical Development
Magenta Therapeutics

Rapid and Robust Mobilization of Hematopoietic Stem Cells With MGTA-145: A Truncated Protein Variant of the Chemokine . . .

Laurie Broadwater

Head of Analytical Chemistry
Thermalin Inc

Reducing the Burden of Insulin Therapy

Mark Edelsward

Director of Business Development
PharmaIN Corp.

PharmaIN makes Peptides better! PharmaIN leverages proprietary platforms for API enhancement and delivery

Richard Liggins

CSO
Zucara Therapeutics

ZT-01, a First in Class Drug to Prevent Hypoglycemia in Type 1 Diabetes

Mark McLaughlin

Mark
Modulation Therapeutics Inc

225Ac-DOTA-MC1RL as a novel therapy for metastatic uveal melanoma

Research Showcase

Brief 15 minute presentations of applied research from the academic labs.

Gerardo Byk

Gerardo
Bar Ilan University

Novel peptide isolated from Middle Asian Tortoise spleen extract induces repopulation of mice bone marrow after . . .

Tambet Teesalu

Professor
University of Tartu, Estonia

Tumor penetrating peptides: discovery and clinical development

Jack Henkin

Research Professor, Chemistry, Center for Developmental Therapuetics
Northwestern University

Peptides enabling extended intravitreal drug delivery as nano-particle conjugates

Peptides in the Clinic

Updates on clinical development of peptide therapeutics.

Bernhard Fischer

CEO
APEPTICO

Design and clinical application of SOLNATIDE, a new peptide for treatment of critical pulmonary dysfunctions

Dieter Willbold

Dieter
Forschungszentrum Jülich

PD, PK and target engagement of the orally available all-D-enantiomeric peptide PRI-002 developed for causal therapy of . . .

Ashok Bhandari

Ashok
Protagonist Therapeutics

PTG-300, AN HEPCIDIN MIMETIC PEPTIDE FOR TREATMENT OF INEFFECTIVE ERYTHROPOIESIS AND CHRONIC ANEMIA IN HEMOGLOBINOPATHY . . .

Emmanuel Dauty

Head of the Physical Chemistry Department
Adocia Inc

Overcoming Formulation and Administration Challenges of Biomolecules BioChaperone® Technology: a Platform to Improve . . .

Nazli Azimi

Founder, President and CEO
Bioniz Therapeutics

Characterization of a Novel, Multi-Cytokine Inhibitor, BNZ-1, for the Treatment of T-cell Malignancies and Alopecia . . .

Steven Prestrelski

Chief Scientific Officer
Xeris Pharmaceuticals, Inc.

XeriSol Formulation Technology for Stable Peptide Injectables

Andy Parker

CSO
Zealand Pharma

Dasiglucagon, a novel ready-to-use glucagon analog in development for treatment of severe hypoglycaemia

Drug Delivery

Novel approaches to peptide drug delivery including devices, molecular engineering, conjugation, and formulation technologies

Harald Rau

Chief Scientific Officer
Ascendis Pharma

TransCon technology for sustained delivery of proteins, peptides, and small molecules

Ruben Boado

Ruben
ArmaGen, Inc.

Brain Penetrating IgG Fusion Proteins: from Genetic Engineering to Clinical Trials in Lysosomal Storage Disorders

Becky Nofsinger

Becky
Merck

Novel Approaches for Evaluating and Enhancing Oral Absorption of Peptides

Ernest Giralt

Professor
IRB Barcelona

Peptides for molecular recognition and brain delivery

Kennett Sprogøe

Senior Vice President, Product Innovation
Ascendis Pharma

TransCon technology for sustained delivery of proteins, peptides, and small molecules

Sheauyu Hsu

Sheauyu Teddy
Adepthera

Development of a novel peptide-centric sustained release system

Advances in Chemistry

James Nowick

Professor and Department Chair
University of California, Irvine, Department of Chemistry

Unlocking the Mysteries of Amyloid Diseases with Macrocyclic β-Sheet Peptides

Erika Olson

Postdoctoral Researcher
Harvard Medical School

Rational Development of a Peptide Antagonist for EphA4, a Cell-Surface Receptor Linked to Neurodegeneration

Megan Thielges

Megan
Indiana University

Site-Specific Infrared Spectroscopy of Conformational Heterogeneity in Proline-Rich Motif Recognition

Carrie Haskell-Luevano

Carrie
University of Minnesota

Peptide GPCR Dimers: opportunities for drug design and chemical probe discovery

Phil Dawson

Professor
TSRI

Peptide macrocycle conformational engineering using a rigid, linear linker

Lin Yan

Principal Scientist
Merck & Co., Inc.

Synthesis and Characterization of Glucose Responsive Insulins

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado

The only conference focused solely on the pharmaceutical development of peptide therapeutics.

Peptide Showcase

Research Showcase

Peptides in the Clinic

Drug Delivery

Advances in Chemistry